Abstract: The present disclosure is concerned with compositions comprising insulin and a pharmaceutically acceptable topical carrier. The present disclosure is also concerned with methods of using these compositions for the treatment of a skin ailment such as a diabetic ulcer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
February 10, 2021
Date of Patent:
June 28, 2022
Assignee:
Eleos Pharmaceuticals, Inc.
Inventors:
Mona E. Buice, David M. Sailors, Joshua Z. Greeson